Clinical Trial

Interscalene Versus Infraspinatus-Teres Minor Blocks for Arthroscopic Shoulder Surgery

Study acronym: ITM-ISB
Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial aims to compare the effectiveness of interscalene (ISB) and infraspinatus-teres minor (ITM) blocks for postoperative analgesia in patients undergoing elective arthroscopic shoulder surgery. The primary outcome is total 24-hour opioid consumption. Secondary outcomes include pain scores, hemidiaphragmatic paresis incidence and severity, duration of analgesia, and changes in lung function. Participants are randomized into ISB or ITM groups; blocks are performed under ultrasound guidance. Postoperative pain is managed with patient controlled analgesia(PCA).
Protocol Amendment History 1 change
critical Trial completed 2026-05-15
Trial Details
NCT Number NCT07253740
Lead Sponsor Ataturk University
Conditions Arthroscopic Shoulder Surgery
Enrollment 60 participants
Start Date 2026-01-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-05-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-14